Conmed (CNMD) Tops Q3 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $50.41 +1.18%
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q3 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $337.9 million versus the consensus estimate of $334.71 million.
GUIDANCE:
Conmed sees FY2025 EPS of $4.48-$4.53, versus the consensus of $4.47. Conmed sees FY2025 revenue of $1.365-1.372 billion, versus the consensus of $1.367 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
